Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a new page build; the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:15.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-05-16T09:07:15.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page’s footer version/release label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the clinical trial information displayed.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:12.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:48:05.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The site revision tag was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:00.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:34:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.